UnitedHealth Group Ranks 28th in Trading Volume Amid Legal Probe and Pharmacy Benefit Reforms

On March 26, 2025, UnitedHealth Group (UNH) saw a trading volume of $1.684 billion, ranking 28th in the day's market activity. The stock price increased by 0.93%.

UnitedHealth Group is currently under investigation by Rosen Law Firm for potential breaches of fiduciary duties by its directors and officers. This investigation has been ongoing since March 2025, with the law firm encouraging investors to come forward with any relevant information. The investigation is part of a broader trend where shareholder interests may clash with corporate governance, highlighting the importance of investor vigilance in ensuring that companies act in their best interests.

In addition to the legal investigation, UnitedHealth Group has made significant strides in improving its pharmacy benefit management services. Optum Rx, a subsidiary of UnitedHealth Group, has announced that it will eliminate up to 25% of the annual reauthorization requirements for certain drugs. This move is aimed at simplifying the pharmacy experience for consumers with chronic conditions and making prescription drugs more affordable. By reducing the need for prior authorizations, Optum Rx hopes to lower the administrative burden on pharmacies and improve access to necessary medications.